tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

FOLD Stock Latest News

Target initiated, Nike upgraded: Wall Street’s top analyst calls
The FlyTarget initiated, Nike upgraded: Wall Street’s top analyst calls
10d ago
DG
HD
Needham upgrades Amicus to Buy on reduced regulatory risk
PremiumThe Fly
Needham upgrades Amicus to Buy on reduced regulatory risk
10d ago
FOLD
Amicus Stock Upgraded to Buy: DMX-200’s Potential and Galafold’s Growth Drive Investment Opportunity
PremiumRatings
Amicus Stock Upgraded to Buy: DMX-200’s Potential and Galafold’s Growth Drive Investment Opportunity
10d ago
FOLD
Amicus upgraded to Buy from Hold at Needham
PremiumThe Fly
Amicus upgraded to Buy from Hold at Needham
10d ago
FOLD
Positive Outlook for Amicus Therapeutics Amid Legal Developments and Patent Confidence
PremiumRatings
Positive Outlook for Amicus Therapeutics Amid Legal Developments and Patent Confidence
11d ago
FOLD
Jefferies says Galafold summary judgment as expected, may facilitate settlement
PremiumThe FlyJefferies says Galafold summary judgment as expected, may facilitate settlement
11d ago
FOLD
Amicus presents four-year data from PROPEL study of Pombiliti, Opfolda
Premium
The Fly
Amicus presents four-year data from PROPEL study of Pombiliti, Opfolda
20d ago
FOLD
Amicus Therapeutics’ Pompe Disease Study: A Potential Game-Changer for Investors
Premium
Company Announcements
Amicus Therapeutics’ Pompe Disease Study: A Potential Game-Changer for Investors
20d ago
FOLD
Amicus Therapeutics’ Global Study on Pompe Disease: A Potential Game-Changer
PremiumCompany Announcements
Amicus Therapeutics’ Global Study on Pompe Disease: A Potential Game-Changer
1M ago
FOLD
Amicus Therapeutics’ Global Study on Pompe Disease: A Potential Game-Changer
PremiumCompany Announcements
Amicus Therapeutics’ Global Study on Pompe Disease: A Potential Game-Changer
2M ago
FOLD
Amicus’s Strong Performance and Growth Potential Drive Buy Rating
PremiumRatings
Amicus’s Strong Performance and Growth Potential Drive Buy Rating
2M ago
FOLD
Amicus price target raised to $18 from $16 at JPMorgan
PremiumThe Fly
Amicus price target raised to $18 from $16 at JPMorgan
2M ago
FOLD
Amicus Therapeutics Reports Strong Growth Amid Strategic Advances
PremiumCompany AnnouncementsAmicus Therapeutics Reports Strong Growth Amid Strategic Advances
2M ago
FOLD
Strong Growth and Strategic Expansion Drive Buy Rating for Amicus Therapeutics
Premium
Ratings
Strong Growth and Strategic Expansion Drive Buy Rating for Amicus Therapeutics
2M ago
FOLD
Amicus Therapeutics: Strong Financial Performance and Strategic Positioning Drive Buy Rating
Premium
Ratings
Amicus Therapeutics: Strong Financial Performance and Strategic Positioning Drive Buy Rating
2M ago
FOLD
Amicus Therapeutics Reports Strong Q2 2025 Growth
PremiumCompany Announcements
Amicus Therapeutics Reports Strong Q2 2025 Growth
2M ago
FOLD
Amicus Therapeutics: Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating
PremiumRatings
Amicus Therapeutics: Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating
2M ago
FOLD
Amicus Therapeutics: Strong Q2 Performance Amid Competitive Uncertainties Warrants Hold Rating
PremiumRatings
Amicus Therapeutics: Strong Q2 Performance Amid Competitive Uncertainties Warrants Hold Rating
2M ago
FOLD
Amicus reports Q2 EPS 1c, consensus 2c
PremiumThe Fly
Amicus reports Q2 EPS 1c, consensus 2c
2M ago
FOLD
Amicus sees FY25 revenue growth 15%-22%
PremiumThe FlyAmicus sees FY25 revenue growth 15%-22%
2M ago
FOLD
FOLD Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
FOLD Earnings this Week: How Will it Perform?
2M ago
FOLD
Starbucks downgraded, Oracle initiated: Wall Street’s top analyst calls
Premium
The Fly
Starbucks downgraded, Oracle initiated: Wall Street’s top analyst calls
2M ago
V
MA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >